DK1630232T3 - Optimerede nukleotidsekvenser kodende for sgp130 - Google Patents

Optimerede nukleotidsekvenser kodende for sgp130

Info

Publication number
DK1630232T3
DK1630232T3 DK04020455T DK04020455T DK1630232T3 DK 1630232 T3 DK1630232 T3 DK 1630232T3 DK 04020455 T DK04020455 T DK 04020455T DK 04020455 T DK04020455 T DK 04020455T DK 1630232 T3 DK1630232 T3 DK 1630232T3
Authority
DK
Denmark
Prior art keywords
sgp130
nucleotide sequences
sequences encoding
optimized nucleotide
encoding sgp130
Prior art date
Application number
DK04020455T
Other languages
English (en)
Inventor
Dirk Seegert
Georg Waetzig
Nikolaus Rahaus
Jessica Daecke
Stefan Rose-John
Original Assignee
Conaris Res Inst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conaris Res Inst Ag filed Critical Conaris Res Inst Ag
Application granted granted Critical
Publication of DK1630232T3 publication Critical patent/DK1630232T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Amplifiers (AREA)
DK04020455T 2004-08-27 2004-08-27 Optimerede nukleotidsekvenser kodende for sgp130 DK1630232T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04020455A EP1630232B1 (en) 2004-08-27 2004-08-27 Optimized nucleotide sequences encoding sgp130

Publications (1)

Publication Number Publication Date
DK1630232T3 true DK1630232T3 (da) 2008-10-20

Family

ID=34926337

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04020455T DK1630232T3 (da) 2004-08-27 2004-08-27 Optimerede nukleotidsekvenser kodende for sgp130

Country Status (11)

Country Link
US (1) US8206948B2 (da)
EP (2) EP1630232B1 (da)
JP (1) JP4615016B2 (da)
AT (1) ATE399868T1 (da)
AU (1) AU2005276581A1 (da)
CA (1) CA2575800C (da)
DE (1) DE602004014758D1 (da)
DK (1) DK1630232T3 (da)
ES (1) ES2309427T3 (da)
PT (1) PT1630232E (da)
WO (1) WO2006021453A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS51544B (en) 2006-06-30 2011-06-30 Conaris Research Institute Ag. POBOLJŠANI SGP 130FC DIMERI
MA41116A (fr) * 2014-12-01 2017-10-10 Ferring Bv Compositions d'inhibiteur de trans-signalisation par l'il-6 sélectif
JP6775513B2 (ja) 2014-12-01 2020-10-28 フェリング・ベー・フェー 選択的il−6−トランス−シグナル伝達阻害剤の投与
GB201522186D0 (en) 2015-12-16 2016-01-27 Singapore Health Services Pte Ltd And Nat University Of Singapore The Treatment of fibrosis
GB201621431D0 (en) * 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore The Decoy cytokine receptor
KR20190096390A (ko) 2016-12-16 2019-08-19 싱가포르 헬스 서비시즈 피티이 엘티디 Il-11 항체
GB201621439D0 (en) 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore IL-11Ra Antibodies
US11319368B2 (en) 2019-01-21 2022-05-03 Singapore Health Services Pte Ltd. Treatment of hepatotoxicity with IL-11 antibody

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
EP1148065B1 (en) * 2000-04-21 2008-01-02 CONARIS research institute AG Fusion proteins comprising two soluble gp130 molecules
JP2004182638A (ja) * 2002-12-03 2004-07-02 Yakult Honsha Co Ltd 炎症性疾患又は悪性腫瘍の予防治療剤
EP1491554A1 (en) * 2003-06-23 2004-12-29 CONARIS research institute AG PEGylated soluble gp130-dimers useful as a medicament

Also Published As

Publication number Publication date
US20080199906A1 (en) 2008-08-21
US8206948B2 (en) 2012-06-26
EP1630232B1 (en) 2008-07-02
WO2006021453A3 (en) 2006-06-22
PT1630232E (pt) 2008-10-02
CA2575800A1 (en) 2006-03-02
JP4615016B2 (ja) 2011-01-19
EP1630232A1 (en) 2006-03-01
JP2008510474A (ja) 2008-04-10
DE602004014758D1 (de) 2008-08-14
ATE399868T1 (de) 2008-07-15
AU2005276581A1 (en) 2006-03-02
EP1791960A2 (en) 2007-06-06
CA2575800C (en) 2018-06-05
WO2006021453A2 (en) 2006-03-02
ES2309427T3 (es) 2008-12-16

Similar Documents

Publication Publication Date Title
BRPI0519766A2 (pt) proteases Ácidas féngicas
DK1622921T3 (da) Varianter af beta-glucosidaser
ATE503009T1 (de) Polypeptide mit lipase-aktivität und diese kodierende polynukleotide
WO2006021453A3 (en) Optimized nucleotide sequences encoding sgp 130
CO6341638A2 (es) Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas y metodos para su uso
ATE491794T1 (de) Zusammensetzung und verfahren zur herstellung von steviolglykosiden
ATE469971T1 (de) Mikroorganismen als träger von für antigene und proteintoxine codierende nukleotidsequenzen, verfahren zur herstellung und verwendungen davon
GB2439039A (en) Identification of a sterol acyltransferase gene
SG156690A1 (en) Mammalian genes involved in infection
EA201001881A1 (ru) Пролинспецифичная протеаза из penicillium chrysogenum
ATE533837T1 (de) Microginin-produzierende proteine und nukleinsäuren, einen microginin gen-cluster kodierend, sowie methoden zur herstellung von microgininen
ATE491809T1 (de) Amplifikation von dna-fragmenten
ATE539163T1 (de) Auf der verwendung von mva beruhende impfstoffe
ATE445009T1 (de) Signalpeptid zur herstellung eines polypeptids
DK2152732T3 (da) Modificeret sekretionssystem til at øge ekspression af polypeptider i bakterier
WO2006076628A3 (en) Compositions comprising promoter sequences and methods of use
DE602006010990D1 (de) Verfahren zur dipeptidherstellung
DE502005007057D1 (de) Verfahren zur herstellung von (s)-butan-2-ol
ATE553194T1 (de) Verfahren zur dipeptidherstellung
ATE403730T1 (de) Gene, die fuer kohlenstoffmetabolismus- und energieproduktions-proteine codieren
DE502006002664D1 (de) Verfahren zur herstellung von lipasen
DK1633873T3 (da) Bakterier med forøgede niveauer af proteinsekretion, nukleotidsekvenser kodende for et SecA-protein med forøgede niveauer af proteinsekretion og fremgangsmåde til fremstilling af proteiner
DE60326716D1 (de) Promoter Sequenzen aus Moos und dessen Verwendung
KR20040053279A (ko) 스트레스 저항성 및 내성 단백질을 코딩하는 유전자
DK1789541T3 (da) Overeksprimeret og renset Aspergillus ficuum-oxidase og nukleinsyre, der koder derfor